ORGENTEC Diagnostika | news and press releases

Mainz, GermanyEffective April 1, 2017, Dr. Michael Bartels, VP Operations, will strengthen the executive management of ORGENTEC Diagnostika GmbH.

Mainz, GermanyWe cordially welcome Dr. Michael Bartels who joins ORGENTEC Diagnostika in the role of Vice President Operations at the company’s headquarters in Mainz.



Mainz, Germany – ORGENTEC Diagnostika has a leading role in the prestigious research project EuroTEAM Arthritis (Towards Early diagnosis and biomarker validation in Arthritis Management), funded by the European Union with more than 5.7 million EUR for four years. Together with partners from 13 renowned European research institutions we present the progress of the project and our contribution to the discovery of novel biomarkers for rheumatoid arthritis at the EuroTEAM stand in the EULAR village from June 08-11.

New products and brand growth win over industry visitors

Merger of ORGENTEC Diagnostika and Corgenix Medical creates a global distribution network and offers more than 350 diagnostic assays

Mainz, Germany – The global diagnostics industry is welcoming ORGENTEC Diagnostika and Corgenix Medical Corporation to the 2015 American Association of Clinical Chemistry (AACC) Clinical Lab Expo in booth #3711. ORGENTEC completed its acquisition of Corgenix in March 2015 and is exhibiting for the first time at AACC. The combined specialty diagnostics company features a portfolio of more than 350 diagnostic tests, including ELISA, IFA, LFI, IT and immunoblot.

Corgenix Transfers to ORGENTEC Exclusive Worldwide Distribution Rights. Effective July 1st.

1000th laboratory device ships to Argentina as a regional art edition

US Affiliate Expands Specialty Diagnostics Company’s Global Presence and Test Menu

Mainz / Düsseldorf - At the world’s biggest trade show for medical technology MEDICA commencing on 12th of November, ORGENTEC joins over 4500 other international exhibitors displaying latest projects and innovations. Therefore, we may give you an update on ORGENTEC’s most recent product developments!

Mainz / Düsseldorf - At the world’s biggest trade show for medical technology MEDICA commencing on 12th of November, ORGENTEC joins over 4500 other international exhibitors displaying latest projects and innovations. Therefore, we may give you an update on ORGENTEC’s most recent product developments!

ORGENTEC acquires Corgenix

Corgenix Enters into Agreement to be Acquired by ORGENTEC Diagnostika

  • Corgenix shareholders to receive $0.27 in cash per share
  • Transaction valued at approximately $16 million
  • Following the transaction, Corgenix will remain headquartered in Broomfield, Colo., as a subsidiary of Orgentec Diagnostika
  • Strategic Acquisition Creates Leading Global Specialty Diagnostics Company

Employer’s Day at ORGENTEC Diagnostika – Students get a Taste of the Laboratory at the Mainz Company Headquarters

Laborführung bei ORGENTEC Dr.Stephan Becker und Prof. Dr. Ulrike Stadtmüller Dr. Holger Bang erklärt den Rheumachec

Mainz - Students from the RheinMain University of Applied Sciences crossed the Rhine for a glimpse of the working world in a Medical Technology company with global reach.
In presentations and discussions with the visitors from the Ruesselsheim campus, a bridge was constructed between the reality of research, the university, and scientific thinking – a successful initiative driven by Biotechnology Professor Dr. Ulrike Stadtmüller and the directors of ORGENTEC.

Water Street Invests in Orgentec Diagnostika

Health Care Firm Partners with European Specialty Diagnostics Company; Former Beckman Coulter Chairman & CEO to Serve as Chairman